Alex Nguyen joined StrideBio as the Vice President of Finance in March 2022. He is primarily responsible for Finance and Accounting operations for the company. Alex was previously the Senior Finance Director and Controller at Brii Biosciences, a biotech based in the US and China tackling unmet public health challenges. During his time there, he helped lead the company’s initial public offering, raising over $340 million. Prior to Brii Bio, he was the Director of Technical Accounting and External Reporting at Parexel and a Director in the Assurance practice at PricewaterhouseCoopers (PwC) focusing on life science companies and IPOs. He holds an MBA and a BS in Accounting from the Rochester Institute of Technology.
Vice President, Finance